Article: Anke Biotechnology to list on GEM.

Anke Biotechnology to list on GEM

Shanghai. September 21. INTERFAX-CHINA - Anhui Anke Biotechnology (Group) Co. Ltd. announced on Sept. 21 that it will make an initial public offering and list on China's upcoming Growth Enterprise Market.

The company will issue 21 million shares from Sept. 25 to raise about RMB 166 million ($24.30 million) for its business expansion, according to the announcement. The new shares will account for no less than 25 percent of Anke Biotechnology's total shares.

A launch date for the Nasdaq-style GEM, the Shenzhen Stock Exchange's secondary exchange for start-up and emerging companies, has not been set as yet.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!